| Last Action | 02/21/19: to Banking & Insurance (H) |
|---|---|
| Title | AN ACT relating to prescription drugs. |
| Bill Documents | Introduced |
| Bill Request Number | 1271 |
| Sponsor | D. Bentley |
| Summary of Original Version | Create new sections of KRS Chapter 217 to define terms; require the Cabinet for Health and Family Services to annually compile a list of certain prescription drugs deemed to be essential to treating diabetes and a list of such drugs that have been subject to a price increase greater than a certain percentage; require drug manufacturers to annually report to the cabinet certain information related to the cost of manufacturing and marketing such drugs and factors that contributed to a price increase; require pharmacy benefit managers to annually report to the cabinet certain information related to prescription drug rebates for such drugs; exempt such information and data reported by manufacturers and pharmacy benefit managers to the cabinet from disclosure pursuant to KRS 61.870 to 61.884; require the cabinet to annually submit to the Legislative Research Commission a report that summarizes the information reported to the cabinet by manufacturers and pharmacy benefit managers; require the cabinet to promulgate administrative regulations necessary to carry out the new sections; amend KRS 217.990 to establish a penalty for failure to report; amend KRS 304.17A-164 to restrict cost-sharing amounts charged by insurers and pharmacy benefit managers; prohibit insurers and pharmacy benefit managers from restricting a pharmacist's ability to inform patients about and to sell less expensive alternative drugs; and amend KRS 304.17A-505 and 304.17C-030 to require disclosure of information related to drug formularies. |
| Index Headings of Original Version |
Diseases - Diabetes, insulin price reporting requirements, establishing Drugs and Medicines - Insulin, price reporting requirements, establishing Insurance, Health - Cost-sharing amounts, restricting Insurance, Health - Drug formulary disclosure, requiring Pharmacists - Sale of less expensive alternative drugs, permitting Administrative Regulations and Proceedings - Cabinet for Health and Family Services, prescription drug price reporting Reports Mandated - Cabinet for Health and Family Services, insulin drug prices |
| 02/20/19 |
|
|---|---|
| 02/21/19 |
|
Last updated: 11/9/2023 3:08 PM (EST)